Evaluation of disk approximation and single-well broth tests for detection of inducible clindamycin resistance in Streptococcus pneumoniae

Journal of Clinical Microbiology

Volumn 49, Issue 9, 2011, Pages 3332-3333

  Jorgensen, James H ^a   McElmeel, M Leticia ^a   Fulcher, Letitia C ^a   McGee, Lesley ^b   Glennen, Anita ^c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DISK DIFFUSION; ERMB GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 80052253256     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00960-11     Document Type: Article

References (12)

1. Bowling, J. E., et al. 2010. Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations. J. Clin. Microbiol. 48:2275-2277.
2. Bradley, J. S., et al. 1998. Pediatric pneumococcal bone and joint infections. Pediatrics 102:1376-1382.
3. Brook, I. 2005. Microbiology and antimicrobial management of sinusitis. J. Laryngol. Otol. 119:251-258.
4. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 8th ed., M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement, M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Craig, A. S., et al. 1999. Carriage of multi-drug-resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center. Clin. Infect. Dis. 29:1257-1264.
7. Diaz, M., M. J. Torres Sanchez, and M. J. Aznar. 2008. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-hemolytic streptococci of Lancefield groups A, B, C, and G in Seville, Spain. Clin. Micrbiol. Infect. 14:85-87.
8. Jenkins, S. G., and D. J. Farrell. 2009. Increase in pneumococcus macrolide resistance, United States. Emerg. Infect. Dis. 15:1260-1264.
9. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
10. Lewis, J. S., II, and J. H. Jorgensen. 2005. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin. Infect. Dis. 40:280-285.
11. McCracken, G. H., Jr. 2002. Diagnosis and management of acute otitis media in the urgent care setting. Ann. Emerg. Med. 39:413-421.
12. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.